Literature DB >> 7291225

Investigations on the CNS sites of action of the discriminative stimulus effects of arecoline and nicotine.

L T Meltzer, J A Rosecrans.   

Abstract

The role of the dorsal hippocampus (DH) and mesencephalic reticular formation (MRF) in mediating the discriminative stimulus (DS) effects of nicotine and arecoline was assessed. In rats trained to discriminate nicotine (1.14 mg/kg) from saline, peripherally administered nicotine generalized to injection of nicotine, but not arecoline, directly into the DH and MRF. The stimulus effect of centrally administered nicotine was antagonized by peripherally administered mecamylamine, but not atropine. Response rate decreases were also observed after nicotine injection into either site. In rats trained to discriminate arecoline (1.74 mg/kg) from saline, peripherally administered arecoline did not generalize to the direct injection of arecoline into the DH and MRF. However, a decrease in response rates was observed after arecoline injection into either site. Thus, The DH and MRF are important in mediating the DS effect of nicotine but not arecoline.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7291225     DOI: 10.1016/0091-3057(81)90332-4

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  6 in total

Review 1.  Neuropharmacology of the interoceptive stimulus properties of nicotine.

Authors:  Thomas E Wooters; Rick A Bevins; Michael T Bardo
Journal:  Curr Drug Abuse Rev       Date:  2009-09

2.  Brain sites involved in the mediation of the behavioral effects of intraventricularly administered (-)-nicotine.

Authors:  V J DeNoble; P C Mele
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

3.  Evidence of cellular nicotinic receptor desensitization in rats exhibiting nicotine-induced acute tolerance.

Authors:  Susan E Robinson; John R James; Laura N Lapp; Robert E Vann; Daniel F Gross; Scott D Philibin; John A Rosecrans
Journal:  Psychopharmacology (Berl)       Date:  2005-07-12       Impact factor: 4.530

4.  Locomotor activity in rats after administration of nicotinic agonists intracerebrally.

Authors:  C Reavill; I P Stolerman
Journal:  Br J Pharmacol       Date:  1990-02       Impact factor: 8.739

5.  The nicotinic antagonist mecamylamine precipitates nicotine abstinence syndrome in the rat.

Authors:  D H Malin; J R Lake; V A Carter; J S Cunningham; K M Hebert; D L Conrad; O B Wilson
Journal:  Psychopharmacology (Berl)       Date:  1994-06       Impact factor: 4.530

Review 6.  The role of NMDA receptor antagonists in nicotine tolerance, sensitization, and physical dependence: a preclinical review.

Authors:  Raka Jain; Kaushiki Mukherjee; Yatan Pal Singh Balhara
Journal:  Yonsei Med J       Date:  2008-04-30       Impact factor: 2.759

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.